Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Pervasis Announces Start of Second Clinical Program, Targeting Peripheral Arterial Disease

Pervasis Therapeutics 04.07.2010

Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel®

Pervasis Therapeutics 02.01.2010

Pervasis Therapeutics Announces $17 Million in Financing and New Board Member

Pervasis Therapeutics 09.16.2009

Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel®

Pervasis Therapeutics 05.05.2009

Pervasis Therapeutics Expands Team to Bring to Market Medical Therapies for Treating Cardiovascular Diseases

Pervasis Therapeutics 09.30.2005

Pervasis Therapeutics Closes $12 Million Series B Financing

Pervasis Therapeutics 09.30.2005

Loading